MHRA:
MHRA: AUTHORISES GEMCITABINE DELIVERY SYSTEM FOR ADULTS WITH BCG-UNRESPONSIVE HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER - WEBSITE
Reuters
MHRA Authorizes Gemcitabine For BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
- Sources
- Reuters
- Language
- English
MHRA: